Genetics, Gene Therapy, and Newborn Screening Explained
TLDR Dr. Wendy Chung delves into genetics, gene therapy, and newborn screening, discussing topics such as PKU, breast cancer, autism, and cardiovascular disease. Genetic testing can help identify diseases early, paving the way for potential treatments and interventions.
Timestamped Summary
00:00
Dr. Wendy Chung discusses genetics, including decoding the human genome, clinical genetic testing, newborn screening, and gene therapy, focusing on conditions such as PKU, breast cancer, obesity, autism, and cardiovascular disease.
07:41
Newborn screening programs for conditions like PKU aim to identify individuals early for intervention to prevent intellectual disabilities.
14:52
There is no known selective advantage to having one copy of the gene associated with PKU, with the condition being more frequent in certain ethnic populations, such as in Ireland, and potentially being a target for gene therapy in the future.
22:00
Data sharing and collaboration among scientists in the early days of genomics led to significant advancements in understanding DNA structure and gene identification, paving the way for future research and discoveries.
29:21
Genetic variation between individuals is vast, but despite this, humans are 99.9% genetically similar, with most genetic differences not affecting bodily functions, while small nucleotide differences can have profound impacts depending on the genes involved and when they are active.
36:47
Genetic testing can be used for reproductive options, assessing cancer risk based on family history or heritage, with targeted tests focusing on specific clinical questions or more comprehensive genomic tests looking at all genes in the genome.
44:15
Mutations can occur over the life course, accumulating in the germ line and leading to increased risk with advanced parental age, with differences in meiosis between sexes impacting the frequency of these mutations.
52:02
Genetic testing can be done using various samples like cheek swabs or blood to analyze specific genes associated with diseases such as breast cancer.
59:40
Genetic testing using cheek swabs or blood samples primarily captures inherited susceptibility rather than changes in genes over time, with liquid biopsies potentially offering a way to detect somatic mutations for cancer screening and recurrence monitoring.
01:07:08
A newborn screening program for Spinal Muscular Atrophy (SMA) has led to early identification and treatment options, resulting in SMA being added to the recommended universal screening panel for babies in the United States, with three FDA approved treatments available.
01:14:29
New York Presbyterian Hospital system is currently conducting newborn sequencing, aiming to expand and integrate it within the public health infrastructure, with a goal of screening about 210,000 babies a year, despite the significant cost challenges and the need for funding from multiple stakeholders.
01:21:59
Gene therapy has evolved over the years, with early examples like the tragic case of Jesse Gelsinger highlighting the risks associated with using adenoviruses as vectors for gene delivery, leading to immunological responses and organ failure, prompting the search for safer delivery systems.
01:29:30
Gene therapy for genetic disorders involves strategies such as gene addition and gene editing, with challenges including the need to selectively target stem cells and avoid off-target effects, making it a complex but promising field for potential treatments.
01:37:19
Tay-Sachs disease can potentially be treated with gene addition strategies, but challenges arise in delivering the missing enzyme to the brain due to its complexity and the need for even distribution throughout.
01:44:39
Genes associated with autism are primarily expressed in the brain and play a crucial role in brain development, with at least 100 genes identified and potentially up to 1000 genes linked to the condition.
01:52:40
Genes associated with autism can have a global effect on brain function and cognition, potentially leading to a range of conditions beyond autism, such as intellectual disabilities, epilepsy, and other global brain function effects.
02:00:12
Genetic factors play a significant role in the heritability of behavioral health and psychiatric conditions, with major depression having lower heritability compared to autism.
02:08:12
Gene editing and therapy costs and affordability, as well as the potential for transformative breakthroughs in genetic therapies in the future, are discussed with a focus on the need for careful consideration of ethical implications and the distinction between somatic cell treatment and germ line manipulation.
02:16:04
The scientific community has rallied around a consensus regarding the ethical implications of gene editing, particularly in response to a controversial case in China involving the manipulation of the CCR5 gene to prevent HIV transmission to offspring, highlighting the importance of upholding ethical standards in genetic research and therapy.
Categories:
Health & Fitness